Search Login Register

Atherosclerosis Summary

Description: A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA.

Also Known As: Atheroscleroses; Atherogenesis

Networked: 37134 relevant articles (1210 outcomes, 5612 trials/studies) for this Disease

Key Drugs and Agents for Atherosclerosis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Cholesterol : 155 outcomes 531 studies in 4670 results : IBA
  2. Lipoproteins (Lipoprotein) : 84 outcomes 439 studies in 4170 results : IBA
  3. Apolipoproteins E (ApoE) : 66 outcomes 276 studies in 1586 results : IBA
  4. Apolipoproteins : 41 outcomes 242 studies in 1547 results : IBA
  5. Apolipoprotein A-I (Apolipoprotein A1) : 29 outcomes 67 studies in 402 results : IBA
  6. Insulin (Novolin) : 28 outcomes 131 studies in 756 results : FDA 2
  7. Estrogens (Estrogen) : 26 outcomes 100 studies in 396 results : FDA 1
  8. Lipids : 25 outcomes 146 studies in 1351 results : IBA
  9. glucuronyl glucosamine glycan sulfate (Vessel) : 25 outcomes 103 studies in 1243 results : IBA
  10. LDL Cholesterol : 25 outcomes 100 studies in 680 results : IBA
Show All >>

Diseases Related to Atherosclerosis

  1. Hypertension (High Blood Pressure)
  2. Cardiovascular Diseases (Cardiovascular Disease)
  3. Inflammation
  4. Hypercholesterolemia
  5. Hyperlipidemias (Hyperlipidemia)
Show All >>

Key Therapies for Atherosclerosis

Efficacy Chart >>
  1. Transplants (Transplant) : 21 outcomes 99 studies in 1018 results
  2. Angioplasty (Angioplasty, Transluminal) : 15 outcomes 30 studies in 429 results
  3. Hormone Replacement Therapy (Therapy, Hormone Replacement) : 9 outcomes 27 studies in 71 results
  4. Stents : 9 outcomes 18 studies in 167 results
  5. Coronary Artery Bypass (Coronary Artery Bypass Surgery) : 6 outcomes 30 studies in 183 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2013 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.